MyFinsight
Home
Compare
Blog
About
Proceeds from the
exercise of stock options
$2,881K
Net cash provided by
financing activities
$2,881K
Net increase
(decrease) in cash and cash...
-$41,306K
Canceled cashflow
$2,881K
Accounts payable
$1,616K
Operating lease
liabilities
$971K
Stock-based compensation
expense
$900K
Non-cash lease expense
$724K
Depreciation expense
$250K
Other assets
-$18K
Net cash used in
operating activities
-$44,174K
Canceled cashflow
$4,479K
Net cash used in
investing activities
-$13K
Net loss
-$44,766K
Prepaid expenses and
other assets
$2,323K
Accrued compensation
-$1,191K
Accrued expenses
-$373K
Purchases of property and
equipment
$13K
Back
Back
Cash Flow
BlossomHill Therapeutics, Inc. (BLSM)
BlossomHill Therapeutics, Inc. (BLSM)
source: myfinsight.com